Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis

Autor: J. W. Wilks, Roberto Montesano, Michael S. Pepper, Lelio Orci, Jean-Dominique Vassalli, Lothar Schweigerer
Jazyk: angličtina
Rok vydání: 1994
Předmět:
Transcription
Genetic

Angiogenesis
Retinoic acid
Betamethasone/analogs & derivatives/pharmacology
Gene Expression
Fibroblast Growth Factor 2/pharmacology
Betamethasone
Biochemistry
Heparin/pharmacology
Transcription
Genetic/drug effects

Neovascularization
chemistry.chemical_compound
Neovascularization
Pathologic/ prevention & control

ddc:576.5
Recombinant Proteins/pharmacology
Cells
Cultured

Plasminogen Activator Inhibitor 1/biosynthesis
Neovascularization
Pathologic

medicine.diagnostic_test
Protease Inhibitors/ pharmacology
Recombinant Proteins
Cell biology
Endothelial stem cell
Endopeptidases/ metabolism
Plasminogen activator inhibitor-1
Fibroblast Growth Factor 2
medicine.symptom
Cell Division
Adrenal Cortex/blood supply
medicine.drug
Cell Division/drug effects
Proteolysis
Suramin
Urokinase-Type Plasminogen Activator/biosynthesis
Tretinoin
Interferon alpha-2
Biology
Endothelium
Vascular/cytology/ drug effects/metabolism

Endopeptidases
Plasminogen Activator Inhibitor 1
medicine
Extracellular
Animals
Humans
Protease Inhibitors
Molecular Biology
Gene Expression/ drug effects
Tretinoin/pharmacology
Heparin
Microcirculation
Interferon-alpha
Cell Biology
Urokinase-Type Plasminogen Activator
Suramin/pharmacology
chemistry
Interferon Alfa-2a/pharmacology
Adrenal Cortex
Cattle
Endothelium
Vascular
Zdroj: Journal of Cellular Biochemistry, Vol. 55, No 4 (1994) pp. 419-434
ISSN: 0730-2312
Popis: A tightly controlled increase in extracellular proteolysis, restricted both in time and space, is an important component of the angiogenic process, while anti-proteolysis is effective in inhibiting angiogenesis. By focussing on the plasminogen activator (PA)-plasmin system, the objective of the present studies was to assess whether previously described inhibitors of angiogenesis modify bovine microvascular endothelial cell proteolytic properties. We demonstrate that although synthetic angiostatic steroids (U-24067 and U-42129), heparin, suramin, interferon alpha-2a, and retinoic acid are all inhibitors of in vitro angiogenesis, each of these agents has distinct effects on the plasminogen-dependent proteolytic system. Specifically, angiostatic steroids and interferon alpha-2a reduce urokinase-type PA (u-PA) and PA inhibitor-1 activity, while heparin and retinoic acid increase u-PA activity. Suramin reduces cell-associated u-PA activity and greatly increases PAI-1 production at doses which induce monolayer disruption. These findings demonstrate that a spectrum of alterations in extracellular proteolysis is associated with anti-angiogenesis, and that anti-angiogenesis and anti-proteolysis are not necessarily correlated. A reduction in extracellular proteolysis would be expected to reduce invasion, whereas an increase in proteolysis might modulate the activity of inhibitory cytokines, which in turn could reduce endothelial cell proliferation and migration and inhibit angiogenesis. The spectrum of effects on different elements of the PA system observed in response to the agents assessed suggests that the role of modulations in extracellular proteolytic activity in anti-angiogenesis is likely to be varied and complex.
Databáze: OpenAIRE